AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of ($0.05), $0.03 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $79.1 million versus the consensus estimate of $81.97 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.